{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T11:44:49Z","timestamp":1775303089898,"version":"3.50.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1353,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.vaccine.2009.09.007","type":"journal-article","created":{"date-parts":[[2009,9,14]],"date-time":"2009-09-14T08:07:16Z","timestamp":1252915636000},"page":"6894-6904","source":"Crossref","is-referenced-by-count":21,"title":["Characterisation of a live Salmonella vaccine stably expressing the Mycobacterium tuberculosis Ag85B\u2013ESAT6 fusion protein"],"prefix":"10.1016","volume":"27","author":[{"given":"Lindsay J.","family":"Hall","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Clare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derek","family":"Pickard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon O.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic L.F.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moataz Abd El","family":"Ghany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Hale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip D.","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon","family":"Dougan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.09.007_bib1","unstructured":"WHO. Joint HIV\/tuberculosis interventions. 2007."},{"key":"10.1016\/j.vaccine.2009.09.007_bib2","unstructured":"WHO. Tuberculosis. Fact Sheet No 104. 2007. [cited; Available from: http:\/\/www.who.int\/mediacentre\/factsheets\/fs104\/en\/]."},{"issue":"March 2 (9)","key":"10.1016\/j.vaccine.2009.09.007_bib3","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1001\/jama.1994.03510330076038","article-title":"Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature","volume":"271","author":"Colditz","year":"1994","journal-title":"JAMA"},{"issue":"November 1 (9)","key":"10.1016\/j.vaccine.2009.09.007_bib4","doi-asserted-by":"crossref","first-page":"6353","DOI":"10.4049\/jimmunol.177.9.6353","article-title":"Mucosal administration of Ag85B\u2013ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity","volume":"177","author":"Dietrich","year":"2006","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.007_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/IAI.01290-06","article-title":"The combined CTA1-DD\/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis","volume":"75","author":"Andersen","year":"2007","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.007_bib6","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.jinf.2005.12.017","article-title":"Protective efficacy of intranasal vaccination with Mycobacterium bovis BCG against airway Mycobacterium tuberculosis challenge in mice","volume":"53","author":"Giri","year":"2006","journal-title":"J Infect"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.007_bib7","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/01.qco.0000168380.08895.9a","article-title":"Recent developments in tuberculosis vaccines","volume":"18","author":"Haile","year":"2005","journal-title":"Curr Opin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.007_bib8","first-page":"62","article-title":"Recent advances in the development of live, attenuated bacterial vectors","volume":"7","author":"Roland","year":"2005","journal-title":"Curr Opin Mol Ther"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.007_bib9","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1172\/JCI0216941","article-title":"Bacterial infectious disease control by vaccine development","volume":"110","author":"Curtiss","year":"2002","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.007_bib10","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1128\/IAI.34.3.746-750.1981","article-title":"Construction of a potential bivalent vaccine strain: introduction of Shigella sonnei form I antigen genes into the galE Salmonella typhi Ty21a typhoid vaccine strain","volume":"34","author":"Formal","year":"1981","journal-title":"Infect Immun"},{"issue":"February 15 (4)","key":"10.1016\/j.vaccine.2009.09.007_bib11","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.4049\/jimmunol.156.4.1504","article-title":"Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant Salmonella","volume":"156","author":"VanCott","year":"1996","journal-title":"J Immunol"},{"issue":"December 12 (5\u20136)","key":"10.1016\/j.vaccine.2009.09.007_bib12","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0264-410X(01)00391-7","article-title":"Safety and immunogenicity of live recombinant Salmonella enterica serovar Typhi Ty21a expressing urease A and B from Helicobacter pylori in human volunteers","volume":"20","author":"Bumann","year":"2001","journal-title":"Vaccine"},{"issue":"May 22 (21)","key":"10.1016\/j.vaccine.2009.09.007_bib13","doi-asserted-by":"crossref","first-page":"4175","DOI":"10.1016\/j.vaccine.2007.03.007","article-title":"Ability of SPI2 mutant of S. Typhi to effectively induce antibody responses to the mucosal antigen enterotoxigenic E. coli heat labile toxin B subunit after oral delivery to humans","volume":"25","author":"Khan","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.007_bib14","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1128\/IAI.68.3.1196-1201.2000","article-title":"Phase 2 clinical trial of attenuated Salmonella enterica serovar typhi oral live vector vaccine CVD 908-htrA in U.S. volunteers","volume":"68","author":"Tacket","year":"2000","journal-title":"Infect Immun"},{"issue":"January 12 (2)","key":"10.1016\/j.vaccine.2009.09.007_bib15","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.vaccine.2005.08.008","article-title":"Evaluation of Salmonella enterica serovar Typhi (Ty2 aroC-ssaV-) M01ZH09, with a defined mutation in the Salmonella pathogenicity island 2, as a live, oral typhoid vaccine in human volunteers","volume":"24","author":"Kirkpatrick","year":"2006","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.007_bib16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1128\/IAI.73.1.362-368.2005","article-title":"Optimization of Salmonella enterica serovar typhi DeltaaroC DeltassaV derivatives as vehicles for delivering heterologous antigens by chromosomal integration and in vivo inducible promoters","volume":"73","author":"Stratford","year":"2005","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.007_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1089\/aid.2006.0098","article-title":"Oral attenuated Salmonella enterica Serovar Typhimurium vaccine expressing codon-optimized HIV Type 1 Gag enhanced intestinal immunity in mice","volume":"23","author":"Tsunetsugu-Yokota","year":"2007","journal-title":"AIDS Res Hum Retrov"},{"issue":"March 31 (19)","key":"10.1016\/j.vaccine.2009.09.007_bib18","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/j.vaccine.2004.11.026","article-title":"Prime-boost vaccine regimen confers protective immunity to human-derived enterotoxigenic Escherichia coli","volume":"23","author":"Lasaro","year":"2005","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.007_bib19","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1128\/IAI.65.4.1286-1292.1997","article-title":"Protection against murine listeriosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the naturally somatic antigen superoxide dismutase","volume":"65","author":"Hess","year":"1997","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.007_bib20","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1128\/IAI.67.5.2145-2152.1999","article-title":"Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A","volume":"67","author":"Ward","year":"1999","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.007_bib21","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1128\/IAI.59.9.3205-3212.1991","article-title":"The genes coding for the antigen 85 complexes of Mycobacterium tuberculosis and Mycobacterium bovis BCG are members of a gene family: cloning, sequence determination, and genomic organization of the gene coding for antigen 85-C of M. tuberculosis","volume":"59","author":"Content","year":"1991","journal-title":"Infect Immun"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.007_bib22","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/nrmicro1211","article-title":"The success and failure of BCG\u2014implications for a novel tuberculosis vaccine","volume":"3","author":"Andersen","year":"2005","journal-title":"Nat Rev Microbiol"},{"issue":"March 23 (2)","key":"10.1016\/j.vaccine.2009.09.007_bib23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1006\/jmbi.2001.4461","article-title":"An interfacial mechanism and a class of inhibitors inferred from two crystal structures of the Mycobacterium tuberculosis 30kDa major secretory protein (Antigen 85B), a mycolyl transferase","volume":"307","author":"Anderson","year":"2001","journal-title":"J Mol Biol"},{"issue":"October 28 (22)","key":"10.1016\/j.vaccine.2009.09.007_bib24","doi-asserted-by":"crossref","first-page":"13001","DOI":"10.1073\/pnas.2235593100","article-title":"Acute infection and macrophage subversion by Mycobacterium tuberculosis require a specialized secretion system","volume":"100","author":"Stanley","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"issue":"June 1 (11)","key":"10.1016\/j.vaccine.2009.09.007_bib25","doi-asserted-by":"crossref","first-page":"6912","DOI":"10.4049\/jimmunol.162.11.6912","article-title":"HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30\/31-kDa antigens","volume":"162","author":"Thole","year":"1999","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2009.09.007_bib26","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm0896-893","article-title":"Immunogenicity and protective efficacy of a tuberculosis DNA vaccine","volume":"2","author":"Huygen","year":"1996","journal-title":"Nat Med"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.007_bib27","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/1521-4141(200006)30:6<1724::AID-IMMU1724>3.0.CO;2-A","article-title":"Efficient protection against Mycobacterium tuberculosis by vaccination with a single subdominant epitope from the ESAT-6 antigen","volume":"30","author":"Olsen","year":"2000","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.007_bib28","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1128\/IAI.68.2.791-795.2000","article-title":"ESAT-6 subunit vaccination against Mycobacterium tuberculosis","volume":"68","author":"Brandt","year":"2000","journal-title":"Infect Immun"},{"issue":"5","key":"10.1016\/j.vaccine.2009.09.007_bib29","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1128\/IAI.69.5.2773-2778.2001","article-title":"Protection of mice with a tuberculosis subunit vaccine based on a fusion protein of antigen 85B and ESAT-6","volume":"69","author":"Olsen","year":"2001","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2009.09.007_bib30","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/IAI.70.6.3111-3121.2002","article-title":"Oral vaccination with subunit vaccines protects animals against aerosol infection with Mycobacterium tuberculosis","volume":"70","author":"Doherty","year":"2002","journal-title":"Infect Immun"},{"issue":"10","key":"10.1016\/j.vaccine.2009.09.007_bib31","doi-asserted-by":"crossref","first-page":"6148","DOI":"10.1128\/IAI.72.10.6148-6150.2004","article-title":"Protective effect of a tuberculosis subunit vaccine based on a fusion of antigen 85B and ESAT-6 in the aerosol guinea pig model","volume":"72","author":"Olsen","year":"2004","journal-title":"Infect Immun"},{"issue":"April 15 (21)","key":"10.1016\/j.vaccine.2009.09.007_bib32","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.vaccine.2004.11.051","article-title":"Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6","volume":"23","author":"Langermans","year":"2005","journal-title":"Vaccine"},{"issue":"February 28 (5)","key":"10.1016\/j.vaccine.2009.09.007_bib33","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1073\/pnas.92.5.1644","article-title":"Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants","volume":"92","author":"Douce","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"September 15 (6)","key":"10.1016\/j.vaccine.2009.09.007_bib34","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.4049\/jimmunol.167.6.3398","article-title":"CTA1-DD-immune stimulating complexes: a novel, rationally designed combined mucosal vaccine adjuvant effective with nanogram doses of antigen","volume":"167","author":"Mowat","year":"2001","journal-title":"J Immunol"},{"issue":"May 21 (5812)","key":"10.1016\/j.vaccine.2009.09.007_bib35","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/291238a0","article-title":"Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines","volume":"291","author":"Hoiseth","year":"1981","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.007_bib36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1128\/IAI.66.2.717-723.1998","article-title":"B-cell epitopes and quantification of the ESAT-6 protein of Mycobacterium tuberculosis","volume":"66","author":"Harboe","year":"1998","journal-title":"Infect Immun"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.007_bib37","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1128\/IAI.73.3.1598-1605.2005","article-title":"Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains","volume":"73","author":"Husseiny","year":"2005","journal-title":"Infect Immun"},{"issue":"June 6 (12)","key":"10.1016\/j.vaccine.2009.09.007_bib38","doi-asserted-by":"crossref","first-page":"6640","DOI":"10.1073\/pnas.120163297","article-title":"One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products","volume":"97","author":"Datsenko","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2009.09.007_bib39","series-title":"Generalized transduction with phage P22","author":"Maloy","year":"1996"},{"issue":"12","key":"10.1016\/j.vaccine.2009.09.007_bib40","doi-asserted-by":"crossref","first-page":"7094","DOI":"10.1128\/IAI.68.12.7094-7099.2000","article-title":"Identification of a Mycobacterium bovis BCG auxotrophic mutant that protects guinea pigs against M. bovis and hematogenous spread of Mycobacterium tuberculosis without sensitization to tuberculin","volume":"68","author":"Chambers","year":"2000","journal-title":"Infect Immun"},{"issue":"January\u2013March (1\u20132)","key":"10.1016\/j.vaccine.2009.09.007_bib41","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tube.2004.09.009","article-title":"Evaluation of vaccines in the EU TB Vaccine Cluster using a guinea pig aerosol infection model of tuberculosis","volume":"85","author":"Williams","year":"2005","journal-title":"Tuberculosis (Edinburgh, Scotland)"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.007_bib42","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1046\/j.1365-2672.2000.00807.x","article-title":"Survival of mycobacterial species in aerosols generated from artificial saliva","volume":"31","author":"Lever","year":"2000","journal-title":"Lett Appl Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.007_bib43","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.68.4.2135-2141.2000","article-title":"Pilot study of phoP\/phoQ-deleted Salmonella enterica serovar typhimurium expressing Helicobacter pylori urease in adult volunteers","volume":"68","author":"Angelakopoulos","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.09.007_bib44","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1999.tb01340.x","article-title":"Live attenuated Salmonella: a paradigm of mucosal vaccines","volume":"171","author":"Sirard","year":"1999","journal-title":"Immunol Rev"},{"key":"10.1016\/j.vaccine.2009.09.007_bib45","series-title":"Defense of mucosal surfaces: pathogenicity, immunity and vaccines","author":"Kraehenbuhl","year":"1998"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.007_bib46","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/j.1574-695X.2000.tb01440.x","article-title":"Kinetics of the mucosal antibody secreting cell response and evidence of specific lymphocyte migration to the lung after oral immunisation with attenuated S. enterica var. typhimurium","volume":"27","author":"Allen","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.007_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0264-410X(96)00159-4","article-title":"Salivary, gut, vaginal and nasal antibody responses after oral immunization with biodegradable microparticles","volume":"15","author":"Challacombe","year":"1997","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.007_bib48","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1128\/CDLI.1.2.150-154.1994","article-title":"Immune response in the lungs following oral immunization with bacterial lysates of respiratory pathogens","volume":"1","author":"Ruedl","year":"1994","journal-title":"Clin Diagn Lab Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.007_bib49","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1128\/IAI.59.3.1206-1209.1991","article-title":"Specific immune response in the human respiratory tract following oral immunization with live typhoid vaccine","volume":"59","author":"Forrest","year":"1991","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.007_bib50","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1574-695X.2000.tb01441.x","article-title":"Protection against murine tuberculosis by an attenuated recombinant Salmonella typhimurium vaccine strain that secretes the 30-kDa antigen of Mycobacterium bovis BCG","volume":"27","author":"Hess","year":"2000","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"July 16 (28\u201329)","key":"10.1016\/j.vaccine.2009.09.007_bib51","doi-asserted-by":"crossref","first-page":"4028","DOI":"10.1016\/S0264-410X(01)00109-8","article-title":"Protective efficacy against tuberculosis of ESAT-6 secreted by a live Salmonella typhimurium vaccine carrier strain and expressed by naked DNA","volume":"19","author":"Mollenkopf","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.09.007_bib52","first-page":"83","article-title":"Development of attenuated Salmonella strains that express heterologous antigens","volume":"87","author":"Bowe","year":"2003","journal-title":"Methods Mol Med"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.007_bib53","first-page":"23","article-title":"Prime-boost immunization strategies for infectious diseases","volume":"4","author":"McShane","year":"2002","journal-title":"Curr Opin Mol Ther"},{"issue":"5\u20136","key":"10.1016\/j.vaccine.2009.09.007_bib54","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.micinf.2005.03.009","article-title":"Prime-boost immunisation strategies for tuberculosis","volume":"7","author":"McShane","year":"2005","journal-title":"Microbes Infect"},{"key":"10.1016\/j.vaccine.2009.09.007_bib55","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.007_bib56","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1128\/IAI.63.3.1134-1137.1995","article-title":"Cholera toxin and Salmonella typhimurium induce different cytokine profiles in the gastrointestinal tract","volume":"63","author":"Klimpel","year":"1995","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.vaccine.2009.09.007_bib57","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1038\/79631","article-title":"Is the development of a new tuberculosis vaccine possible?","volume":"6","author":"Kaufmann","year":"2000","journal-title":"Nat Med"},{"issue":"December 1 (6)","key":"10.1016\/j.vaccine.2009.09.007_bib58","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1084\/jem.178.6.2249","article-title":"An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection","volume":"178","author":"Flynn","year":"1993","journal-title":"J Exp Med"},{"key":"10.1016\/j.vaccine.2009.09.007_bib59","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.15.1.749","article-title":"Cellular responses to interferon-gamma","volume":"15","author":"Boehm","year":"1997","journal-title":"Annu Rev Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2009.09.007_bib60","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S1369-5274(00)00199-5","article-title":"The role of gamma interferon in antimicrobial immunity","volume":"4","author":"Shtrichman","year":"2001","journal-title":"Curr Opin Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2009.09.007_bib61","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0167-5699(98)01321-8","article-title":"Novel human immunodeficiencies reveal the essential role of type-I cytokines in immunity to intracellular bacteria","volume":"19","author":"Ottenhoff","year":"1998","journal-title":"Immunol Today"},{"issue":"January 1 (1)","key":"10.1016\/j.vaccine.2009.09.007_bib62","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4049\/jimmunol.158.1.315","article-title":"T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection","volume":"158","author":"Murray","year":"1997","journal-title":"J Immunol"},{"issue":"November 1 (9)","key":"10.1016\/j.vaccine.2009.09.007_bib63","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.4049\/jimmunol.165.9.4778","article-title":"Cutting edge: the mucosal adjuvant cholera toxin redirects vaccine proteins into olfactory tissues","volume":"165","author":"van Ginkel","year":"2000","journal-title":"J Immunol"},{"issue":"November 1 (9)","key":"10.1016\/j.vaccine.2009.09.007_bib64","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1086\/491739","article-title":"Proinflammatory responses in the murine brain after intranasal delivery of cholera toxin: implications for the use of AB toxins as adjuvants in intranasal vaccines","volume":"192","author":"Armstrong","year":"2005","journal-title":"J Infect Dis"},{"issue":"February 26 (9)","key":"10.1016\/j.vaccine.2009.09.007_bib65","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJMp048006","article-title":"Nasal vaccination, Escherichia coli enterotoxin, and Bell's palsy","volume":"350","author":"Couch","year":"2004","journal-title":"N Engl J Med"},{"issue":"February 26 (9)","key":"10.1016\/j.vaccine.2009.09.007_bib66","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.007_bib67","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1128\/MMBR.53.4.390-409.1989","article-title":"Pathogenesis and immunity in murine salmonellosis","volume":"53","author":"Hsu","year":"1989","journal-title":"Microbiol Rev"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.007_bib68","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1128\/IAI.8.2.165-172.1973","article-title":"Interactions between macrophages of guinea pigs and salmonellae. 3. Bactericidal action and cytophilic antibodies of macrophages of infected guinea pigs","volume":"8","author":"Hsu","year":"1973","journal-title":"Infect Immun"},{"issue":"4","key":"10.1016\/j.vaccine.2009.09.007_bib69","first-page":"343","article-title":"Acquired resistance to and comparative virulence of Salmonella typhimurium demonstrated by cutaneous lesions in guinea pigs","volume":"11","author":"Hsu","year":"1972","journal-title":"J Reticuloendoth Soc"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.007_bib70","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1128\/JB.96.1.191-197.1968","article-title":"Interactions between macrophages of guinea pigs and Salmonellae. I. Fate of Salmonella typhimurium within macrophages of normal guinea pigs","volume":"96","author":"Hsu","year":"1968","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.007_bib71","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1128\/IAI.18.1.52-59.1977","article-title":"Interactions between salmonellae and macrophages of guinea pigs. IV. Relationship between migration inhibition and antibacterial action of macrophages","volume":"18","author":"Mayo","year":"1977","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.vaccine.2009.09.007_bib72","first-page":"1","article-title":"Effect of kanamycin on the fate of Salmonella enteritidis within cultured macrophages of guinea pigs","volume":"15","author":"Rhodes","year":"1974","journal-title":"J Reticuloendoth Soc"},{"issue":"2","key":"10.1016\/j.vaccine.2009.09.007_bib73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1128\/IAI.2.2.145-149.1970","article-title":"Interactions between macrophages of guinea pigs and Salmonellae. II. Phagocytosis of Salmonella typhimurium by macrophages of normal guinea pigs","volume":"2","author":"Wells","year":"1970","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09013310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,26]],"date-time":"2023-05-26T18:53:50Z","timestamp":1685127230000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09013310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":73,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0264410X09013310"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.09.007","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}